toxicidad renal de los inhibidores checkpoint
Published 2 years ago • 736 plays • Length 32:53Download video MP4
Download video MP3
Similar videos
-
1:00
review of the renal endpoints used in cardiovascular safety clinical trials in type 2 diabetes
-
4:23
irene alperin - conferencia inaugural. classification of pituitary tumors for the clinicians
-
57:20
controversia | nefrotoxicidad por inhibidores checkpoint
-
0:58
renal transplantation from positive hepatitis c donors to negative recipients
-
6:45
understanding renal cancer: types, symptoms, and management
-
2:33
the effect of lymphodepleting agents on rate and severity of toxicities following car-t infusion
-
1:03
checkpoint inhibitors in anal cancer
-
1:36
terapia dirigida y cáncer de riñón | inhibidores de angiogénesis y quinasa | nkf
-
1:12:48
session 1: why consider hypofractionation
-
10:24
the typical prognosis of aggressive renal cell cancer
-
50:00
nonsteroidal mineralocorticoid receptor antagonists & cardiorenal outcomes in chronic kidney disease
-
25:42
differential tumour microenvironment response to pd 1 checkpoint inhibition - by shinjini
-
1:32
lung cancer immuno-oncology clinical trial combinations: inhibiting ido
-
27:10
#6 - immune checkpoint inhibitors, with sandra herrmann
-
0:34
managing acute and long-term side effects in checkpoint inhibitors for melanoma
-
3:31
perioperative strategies in high-risk and oligometastatic renal cell and urothelial cancers
-
2:57
when can checkpoint inhibitors be used to treat urothelial carcinoma?
-
1:37
dr. lara on the potential role of ido inhibitors in the treatment of rcc
-
54:43
all-cause and immune checkpoint inhibitor-associated acute kidney injury
-
4:50
randomized phase iii clinical trial of neoadjuvant intravesical mitomycin c treatment
-
6:13
remco molenaar, md, phd: tet2 mutations predict cardiovascular risk in mds and cmml